Standardizing Compliance Across Private Equity Healthcare Portfolios: Case Study Insights
Buying a healthcare practice does not mean its compliance program is
ready to join the rest of the portfolio.
One location may have current policies and regular training. Another may
rely on an outdated handbook. Employees at a third practice might not know
where to report a concern.
Getting these organizations on the same page takes more than sending out
a shared policy manual. Leaders need a way to identify problems, assign
responsibility, and make sure issues get resolved. They also need to account
for differences in services, state laws, and day-to-day operations.
Government guidance and enforcement actions offer some useful lessons on
where to start.
A Shared Policy Manual Is Only the Beginning
The HHS Office of Inspector General (OIG) outlines seven elements of an
effective compliance program:
- Written policies and procedures.
- Compliance leadership and
oversight.
- Training and education.
- Communication and reporting
channels.
- Consistent enforcement of
standards.
- Risk assessment, auditing, and
monitoring.
- Responses to problems and
corrective action.
These elements provide a starting point for organizations across a
healthcare portfolio. OIG's General Compliance Program Guidance is voluntary,
though. It does not require every organization to operate an identical program.
The practical goal is to establish common expectations while leaving room
for the requirements and risks of each business.
For example, every organization should know how to report a compliance
concern. The person responsible for investigating it may differ by location or
type of issue.
Case Study: Patient Care America
A federal settlement involving Patient Care America shows why compliance
oversight needs to extend beyond the practice or billing office.
In 2019, the Department of Justice announced that the compounding
pharmacy, two executives, and private equity firm Riordan, Lewis & Haden
agreed to pay approximately $21.36 million to resolve False Claims Act
allegations involving prescriptions reimbursed by TRICARE.
The government alleged that the pharmacy paid outside marketers to
generate prescriptions for compounded creams and vitamins regardless of patient
need. It also alleged that the private equity firm knew of and agreed to the
marketing arrangement and financed the kickback payments.
The settlement resolved allegations. There was no determination of
liability.
What portfolio leaders can take from this case
Marketing arrangements and funding decisions deserve compliance
attention, just as billing and documentation do.
Practical steps include:
- Reviewing marketing and
referral-related agreements before they are signed.
- Looking closely at compensation
tied to healthcare business.
- Investigating unusual growth in
high-reimbursement services.
- Giving compliance staff a way to
raise concerns about business decisions.
- Documenting how leadership
addressed those concerns.
These steps reflect OIG's broader recommendation to examine financial
incentives and "follow the money" when evaluating potential compliance risks.
Common Ownership Does Not Remove Referral Risks
It can be easy to assume that arrangements between businesses in the same
portfolio are less risky than arrangements with outside companies.
That assumption can cause problems.
OIG explains that common ownership does not automatically protect
payments between organizations from scrutiny under the federal Anti-Kickback
Statute. The facts and intent behind an arrangement still matter.
A portfolio might include physician practices and other healthcare
businesses that serve the same patients. Before introducing referral processes,
shared marketing arrangements, or payments between those businesses, leaders
should have the arrangements reviewed.
Internal relationships should not bypass the review process simply
because the organizations share an investor.
What Should Be Consistent Across the Portfolio?
Not every procedure needs to be identical. Some basic processes, however,
are easier to oversee when organizations use a common approach.
|
Area |
A practical approach |
|
Leadership |
Identify who handles compliance
locally and which issues must go to portfolio leadership or the governing
body. |
|
Policies |
Use approved core policies with a
process for local changes and updates. |
|
Training |
Set common expectations, then add
education for specific jobs and services. |
|
Reporting |
Give employees clear reporting
options and explain the organization's nonretaliation expectations. |
|
Auditing |
Use a consistent process to document
findings and assign corrective actions. |
|
Follow-up |
Check whether corrective actions
worked, not just whether someone marked them complete. |
These are suggested ways to apply OIG's compliance framework. They are
not a separate government requirement for managing a healthcare portfolio.
Where Local Differences Still Matter
A policy that works for one organization may not address another
organization's risks.
A physician practice and a compounding pharmacy, for example, may need
different auditing priorities. Their services, billing practices, and business
relationships are not the same.
State requirements also need attention. HIPAA generally does not override
contrary state health information privacy laws that provide more stringent
protections. A shared privacy policy may need state-specific provisions.
One workable approach is to use:
- A core policy that sets the
common standard.
- Local procedures that explain how
employees carry it out.
- State-specific additions where
needed.
- A designated person responsible
for updates.
This keeps organizations from starting from scratch without forcing every
location to use instructions that do not fit its work.
Bringing a Newly Acquired Practice Into the Program
A new acquisition is a good time to look closely at existing practices.
It is not a reason to assume that everything is in order.
The following steps offer a practical way to organize that review.
Start with what is already there
Gather policies, training records, prior audits, complaints, and open
corrective-action plans.
Look for unresolved issues as well as missing documents. An organization
may have a policy on paper while employees follow a different process.
Make responsibility clear
Employees need to know who handles questions and concerns after the
acquisition. Local managers also need to understand which issues they can
address and which require escalation.
Do not leave those decisions to guesswork.
Review the higher-risk activities first
The priorities will depend on the organization. Areas to consider include
billing, documentation, marketing, referral relationships, and patient
information safeguards.
Use the organization's actual risks to guide the work rather than
applying the same checklist in the same order everywhere.
Check whether changes are working
Sending a policy and collecting acknowledgments does not show whether the
process works.
Ask employees how they would handle a concern. Review a sample of work.
Follow up on earlier findings. These checks can reveal gaps that training
records alone will not show.
Look Beyond Completion Rates
Training completion and policy acknowledgments have a place in compliance
reporting. They should not be the only things leadership sees.
A more useful report may also show:
- Findings that keep coming back.
- Corrective actions that are
overdue.
- Problems reported at more than
one organization.
- Issues that need a leadership
decision.
- Follow-up results showing whether
a problem was resolved.
This gives leaders a better chance of spotting a wider issue before each
organization has to discover it separately.
The value of a shared compliance program is not the number of policies it
produces. It is whether people recognize concerns, report them, and take
appropriate action.
Frequently Asked Questions
Does OIG require every organization in
a private equity healthcare portfolio to use the same compliance program?
No. OIG's General Compliance Program Guidance is voluntary and allows
organizations to tailor their programs to their circumstances. Separate laws,
regulations, contracts, or settlement obligations may impose specific
requirements.
Can organizations under common
ownership refer patients to each other?
Common ownership does not automatically make a referral or payment
arrangement permissible. OIG explains that payments between commonly owned
entities can raise Anti-Kickback Statute concerns. Arrangements need review
based on the facts and applicable requirements.
Can one policy manual cover the entire
portfolio?
A shared manual can establish common expectations, but it may need local
procedures and state-specific additions. It should reflect the services and
requirements of the organizations using it.
Can a private equity investor be
included in a healthcare enforcement action?
Yes. The Patient Care America settlement included a private equity firm
based on allegations about its involvement in the challenged arrangement. The
settlement did not establish liability, but it illustrates why investor-level
decisions also need compliance review.
Where should portfolio leaders start?
Start by identifying who is responsible for compliance and reviewing the
risks at each organization. Compare existing practices with OIG's seven
compliance program elements, prioritize significant gaps, and follow corrective
actions through to completion.
Sources
- HHS Office of Inspector General, General
Compliance Program Guidance. Covers the seven compliance program
elements, private investment in healthcare, financial incentives, and
tailoring compliance programs to organizational risks. https://oig.hhs.gov/documents/compliance-guidance/1135/HHS-OIG-GCPG-2023.pdf
- U.S. Department of Justice, Compounding
Pharmacy, Two of Its Executives, and Private Equity Firm Agree to Pay
$21.36 Million to Resolve False Claims Act Allegations. Provides the
Patient Care America settlement details and explains that there was no
determination of liability. https://www.justice.gov/usao-sdfl/pr/compounding-pharmacy-two-its-executives-and-private-equity-firm-agree-pay-2136-million
- HHS Office of Inspector General, General
Questions Regarding Certain Fraud and Abuse Authorities. Addresses
Anti-Kickback Statute considerations for arrangements between commonly
owned entities. https://oig.hhs.gov/faqs/general-questions-regarding-certain-fraud-and-abuse-authorities/
- U.S. Department of Justice, South Carolina Medical Association v. HHS, Opposition. Discusses HIPAA preemption and the treatment of more stringent state privacy laws. https://www.justice.gov/osg/brief/so-carolina-med-assn-v-hhs-opposition